REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 86 filers reported holding REVANCE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,573,740 | +1.0% | 79,905 | -15.4% | 0.51% | -8.7% |
Q3 2022 | $2,549,000 | +138.4% | 94,413 | +122.0% | 0.55% | +119.0% |
Q3 2020 | $1,069,000 | +38.8% | 42,537 | +34.8% | 0.25% | +48.8% |
Q2 2020 | $770,000 | -39.0% | 31,552 | -63.0% | 0.17% | -56.6% |
Q1 2020 | $1,262,000 | -26.2% | 85,302 | -19.1% | 0.39% | +4.3% |
Q4 2019 | $1,711,000 | -50.9% | 105,429 | -6.8% | 0.38% | -35.2% |
Q1 2018 | $3,483,000 | -9.2% | 113,096 | +5.4% | 0.58% | -15.6% |
Q4 2017 | $3,837,000 | +92.0% | 107,333 | +48.0% | 0.69% | +158.3% |
Q3 2017 | $1,998,000 | +123.2% | 72,518 | +113.9% | 0.27% | +79.7% |
Q2 2017 | $895,000 | -74.5% | 33,897 | -67.0% | 0.15% | -67.8% |
Q4 2015 | $3,512,000 | +96.1% | 102,800 | +95.2% | 0.46% | +35.0% |
Q2 2014 | $1,791,000 | – | 52,668 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |